Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Es

Showing results (361-370 of 480) with videos related to

Pageof 48
Sort By:
Neuromuscular Disorders : NMD|May 31, 2022
Distal spinal muscular atrophy featured by predominant calf muscle involvement in VRK1 associated disease - Case series and reviewKoen Demaegd, Eva H Brilstra, Jessica E Hoogendijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2022
Characterising ALS disease progression according to El Escorial and Gold Coast criteriaAdriaan D de Jongh, Nathalie Braun, Markus Weber, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 29, 2019
A neuropsychological and behavioral study of PLSBálint S de Vries, Lauriane A Spreij, Laura M M Rustemeijer, et al.
Critical Care Research and Practice|October 23, 2018
Outcome in Patients with Isolated Moderate to Severe Traumatic Brain InjuryD Jochems, K J P van Wessem, R M Houwert, et al.
Clinical and Experimental Immunology|January 1, 1994
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gammaM E van den Dobbelsteen, V Verhasselt, J G Kaashoek, et al.
Neurobiology of Aging|November 13, 2012
Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3Max Koppers, Ewout J N Groen, Paul W J van Vught, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 1, 2025
Serum small non-coding RNA define molecular subtypes in amyotrophic lateral sclerosisSharada Baindoor, Hesham A Y Gibriel, Lindy Kool, et al.
European Journal of Neurology|September 2, 2018
Diagnostic value of emergency medical services provider judgement in the identification of head injuries among trauma patientsE A J van Rein, D Jochems, R D Lokerman, et al.
The New England Journal of Medicine|May 4, 2000
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic EventsW W O'Neill, P Serruys, M Knudtson, et al.
Neurobiology of Aging|August 2, 2011
Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patientsMarka van Blitterswijk, Paul W J van Vught, Michael A van Es, et al.
Pageof 48

Showing results (361-370 of 480) with videos related to

Sort By:
Pageof 48
Neuromuscular Disorders : NMD|May 31, 2022
Distal spinal muscular atrophy featured by predominant calf muscle involvement in VRK1 associated disease - Case series and reviewKoen Demaegd, Eva H Brilstra, Jessica E Hoogendijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2022
Characterising ALS disease progression according to El Escorial and Gold Coast criteriaAdriaan D de Jongh, Nathalie Braun, Markus Weber, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 29, 2019
A neuropsychological and behavioral study of PLSBálint S de Vries, Lauriane A Spreij, Laura M M Rustemeijer, et al.
Critical Care Research and Practice|October 23, 2018
Outcome in Patients with Isolated Moderate to Severe Traumatic Brain InjuryD Jochems, K J P van Wessem, R M Houwert, et al.
Clinical and Experimental Immunology|January 1, 1994
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gammaM E van den Dobbelsteen, V Verhasselt, J G Kaashoek, et al.
Neurobiology of Aging|November 13, 2012
Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3Max Koppers, Ewout J N Groen, Paul W J van Vught, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 1, 2025
Serum small non-coding RNA define molecular subtypes in amyotrophic lateral sclerosisSharada Baindoor, Hesham A Y Gibriel, Lindy Kool, et al.
European Journal of Neurology|September 2, 2018
Diagnostic value of emergency medical services provider judgement in the identification of head injuries among trauma patientsE A J van Rein, D Jochems, R D Lokerman, et al.
The New England Journal of Medicine|May 4, 2000
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic EventsW W O'Neill, P Serruys, M Knudtson, et al.
Neurobiology of Aging|August 2, 2011
Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patientsMarka van Blitterswijk, Paul W J van Vught, Michael A van Es, et al.
Pageof 48